Mineralys Therapeutics, Inc. (MLYS)
29.26
+0.23
(+0.79%)
USD |
NASDAQ |
Feb 27, 16:00
29.30
+0.04
(+0.14%)
After-Hours: 20:00
Mineralys Therapeutics Shareholders Equity (Quarterly) : 576.43M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 738.98M |
| Nektar Therapeutics | 85.09M |
| Lyell Immunopharma, Inc. | 329.12M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
| Celcuity, Inc. | 116.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 599.95M |
| Total Liabilities (Quarterly) | 23.52M |
| Current Ratio | 25.50 |